AVTX
Avalo Therapeutics Inc
NASDAQ: AVTX · HEALTHCARE · BIOTECHNOLOGY
$19.94
-3.75% today
Updated 2026-06-05
Market cap
$733.82M
P/E ratio
—
P/S ratio
12,437.55x
EPS (TTM)
$-5.57
Dividend yield
—
52W range
$4 – $24
Volume
1.7M
Avalo Therapeutics Inc (AVTX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
—
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|